Thermo Fisher Scientific earnings missed by $0.28, revenue fell short of estimates

Investing.com – Thermo Fisher Scientific (NYSE: ) reported second quarter EPS of $5.15, $0.28 worse than the analyst estimate of $5.43. Revenue for the quarter came in at $10.69B versus the consensus estimate of $10.99B.

Guidance

Thermo Fisher Scientific sees FY 2023 EPS of $22.28-$22.72 versus the analyst consensus of $23.55.

Thermo Fisher Scientific sees FY 2023 revenue of $43.40B-$44.00B versus the analyst consensus of $45.21B.

Thermo Fisher Scientific’s stock price closed at $570.91. It is up 2.89% in the last 3 months and down -1.89% in the last 12 months.

Thermo Fisher Scientific saw 2 positive EPS revisions and 17 negative EPS revisions in the last 90 days. See Thermo Fisher Scientific’s stock price’s past reactions to earnings here.

According to InvestingPro, Thermo Fisher Scientific’s Financial Health score is “great performance”.

Check out Thermo Fisher Scientific’s , and Thermo Fisher Scientific’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar